Literature DB >> 24522512

Codevelopment of genome-based therapeutics and companion diagnostics: insights from an Institute of Medicine roundtable.

Robert T McCormack1, Joanne Armstrong2, Debra Leonard3.   

Abstract

Mesh:

Substances:

Year:  2014        PMID: 24522512     DOI: 10.1001/jama.2014.1508

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  5 in total

Review 1.  An evaluation of regulatory and commercial barriers to stratified medicine development and adoption.

Authors:  N A Meadows; A Morrison; D A Brindley; A Schuh; R W Barker
Journal:  Pharmacogenomics J       Date:  2014-10-07       Impact factor: 3.550

2.  Standardization of amniotic fluid leptin levels and utility in maternal overweight and fetal undergrowth.

Authors:  M Scott-Finley; J G Woo; M Habli; O Ramos-Gonzales; J F Cnota; Y Wang; B D Kamath-Rayne; A C Hinton; W J Polzin; T M Crombleholme; R B Hinton
Journal:  J Perinatol       Date:  2015-04-30       Impact factor: 2.521

Review 3.  Advances in the treatment of aortic valve disease: is it time for companion diagnostics?

Authors:  Robert B Hinton
Journal:  Curr Opin Pediatr       Date:  2014-10       Impact factor: 2.856

4.  A Quantitative Assessment of Factors Affecting the Technological Development and Adoption of Companion Diagnostics.

Authors:  Dee Luo; James A Smith; Nick A Meadows; A Schuh; Katie E Manescu; Kim Bure; Benjamin Davies; Rob Horne; Mike Kope; David L DiGiusto; David A Brindley
Journal:  Front Genet       Date:  2016-01-28       Impact factor: 4.599

5.  A Practical Guide to Modeling and Conducting a Cost-Effectiveness Analysis of Companion Biomarker Tests for Targeted Therapies Using R: Tutorial Paper.

Authors:  Mikyung Kelly Seo; Mark Strong
Journal:  Pharmacoeconomics       Date:  2021-08-20       Impact factor: 4.981

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.